REPAGLINIDE ACCORD

1MG TBL NOB 90

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 01.09.2020
Interruption of marketing 15.07.2020 0202881, 0026777
Manufacturing reasons 01.10.2020
Placing on the market 12.02.2018

All reports are available in the Overview.

Back to list